151 related articles for article (PubMed ID: 28110554)
1. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.
Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S
J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis of A549 cells by small interfering RNA targeting survivin delivery using poly-β-amino ester/guanidinylated O-carboxymethyl chitosan nanoparticles.
Tang Y; Liu Y; Xie Y; Chen J; Dou Y
Asian J Pharm Sci; 2020 Jan; 15(1):121-128. PubMed ID: 32175024
[TBL] [Abstract][Full Text] [Related]
3. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
4. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
[TBL] [Abstract][Full Text] [Related]
5. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K
Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628
[TBL] [Abstract][Full Text] [Related]
6. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
[TBL] [Abstract][Full Text] [Related]
7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
8. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
[TBL] [Abstract][Full Text] [Related]
10. GABA
Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
[TBL] [Abstract][Full Text] [Related]
11. The immunostimulatory effects of hydroxypropyltrimethyl ammonium chloride chitosan-carboxymethyl chitosan nanoparticles.
Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
Int J Biol Macromol; 2021 Jun; 181():398-409. PubMed ID: 33781818
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.
Zhao K; Sun Y; Chen G; Rong G; Kang H; Jin Z; Wang X
Carbohydr Polym; 2016 Sep; 149():28-39. PubMed ID: 27261727
[TBL] [Abstract][Full Text] [Related]
13. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory effect of N-2-hydroxypropyltrimethyl ammonium chloride chitosan-sulfate chitosan complex nanoparticles on dendritic cells.
Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
Carbohydr Polym; 2021 Jan; 251():117098. PubMed ID: 33142636
[TBL] [Abstract][Full Text] [Related]
16. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
[TBL] [Abstract][Full Text] [Related]
17. Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles.
Li GF; Wang JC; Feng XM; Liu ZD; Jiang CY; Yang JD
Appl Biochem Biotechnol; 2015 Apr; 175(7):3244-57. PubMed ID: 25686559
[TBL] [Abstract][Full Text] [Related]
18. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
Wei W; Lv PP; Chen XM; Yue ZG; Fu Q; Liu SY; Yue H; Ma GH
Biomaterials; 2013 May; 34(15):3912-23. PubMed ID: 23453062
[TBL] [Abstract][Full Text] [Related]
19. Immune enhancement of N-2-Hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nanoparticles vaccine.
Gao Y; Gong X; Yu S; Jin Z; Ruan Q; Zhang C; Zhao K
Int J Biol Macromol; 2022 Nov; 220():183-192. PubMed ID: 35981671
[TBL] [Abstract][Full Text] [Related]
20. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
